The efficacy of high- and low-dose intravenous omeprazole in preventing rebleeding for patients with bleeding peptic ulcers and comorbid illnesses

Digestive Diseases and Sciences

Volumn 50, Issue 7, 2005, Pages 1194-1201

  Cheng, Hsiu Chi ^a   Kao, Ai Wen ^a   Chuang, Chiao Hsiung ^a   Sheu, Bor Shyang ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Comorbid illnesses; Hypoalbuminemia; Omeprazole infusion; Peptic ulcer bleeding

Indexed keywords

OMEPRAZOLE; SERUM ALBUMIN; ANTIULCER AGENT; CREATINE; ENZYME INHIBITOR;

ADULT; AGED; ALBUMIN BLOOD LEVEL; ARTICLE; BLEEDING; CLINICAL TRIAL; COMORBIDITY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG INFUSION; DRUG MEGADOSE; ENDOSCOPY; FEMALE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PATIENT; PEPTIC ULCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; BLOOD; CHRONIC KIDNEY FAILURE; DOSE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; METABOLISM; MIDDLE AGED; PEPTIC ULCER BLEEDING; RECURRENT DISEASE; STATISTICAL MODEL;

AGED; ANTI-ULCER AGENTS; CREATINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; FEMALE; HUMANS; INJECTIONS, INTRAVENOUS; KIDNEY FAILURE, CHRONIC; LOGISTIC MODELS; MALE; MIDDLE AGED; OMEPRAZOLE; PEPTIC ULCER HEMORRHAGE; RECURRENCE; SERUM ALBUMIN;

EID: 23044438475     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10620-005-2759-6     Document Type: Article

References (26)

1. Katschinski B, Logan R, Davies J, Faulkner G, Pearson J, Langman M: Prognostic factors in upper gastrointestinal bleeding. Dig Dis Sci 39:706-712, 1994
2. Yavorski RT, Wong RK, Maydonovitch C, Battin LS, Furnia A, Amundson DE: Analysis of 3,294 cases of upper gastrointestinal bleeding in military medical facilities. Am J Gastroenterol 90:568-573, 1995
3. Jensen DM, Kovacs TOG, Randall GM, Machicado GA, Jensen ME, You S, Pelayo E: Prospective study of patients who developed severe ulcer bleeding as inpatients compared to outpatients. Gastrointest Endosc 38:235 (A38), 1992 (abstract)
4. Terdiman JP, Ostroff JW: Gastrointestinal bleeding in the hospitalized patient: a case-control study to assess risk factors, causes, and outcome. Am J Med 104:349-354, 1998
5. Lau JY, Sung JJ, Lee KK, Yung MY, Wong SK, Wu JC, Chan FK, Ng EK, You JH, Lee CW, Chan AC, Chung SC: Effect of intravenous omeprazole on recurrent bleeding after endoscopic treatment of bleeding peptic ulcers. N Engl J Med 343:310-316, 2000
6. Schaffalitzky de Muckadell OB, Havelund T, Harling H, Boesby S, Snel P, Vreeburg EM, Eriksson S, Fernström P, Hasselgren G: Effect of omeprazole on the outcome of endoscopically treated bleeding peptic ulcers: Randomized double-blind placebo-controlled multicentre study. Scand J Gastroenterol 32:320-327, 1997
7. Sheu BS, Chi CH, Huang CC, Kao AW, Wang YL, Yang HB: Impact of intravenous omeprazole on Helicobacter pylori eradication by triple therapy in patients with peptic ulcer bleeding. Aliment Pharmacol Ther 16:137-143, 2002
8. Lam SK, Hasan M, Sircus W, Wong J, Ong GB, Prescott RJ: Comparison of maximal acid output and gastrin response to meals in Chinese and Scottish normal and duodenal ulcer subjects. Gut 21:324-328, 1980
9. Bertilsson L: Geographic/interracial differences in polymorphic drug oxidation. Current state of knowledge of cytochromes P450 (CYP) 2D6 and 2C19. Clin Pharmacokinet 29:192-209, 1995
10. Cheng HC, Chuang SA, Kao YH, Kao AW, Chuang CH, Sheu BS: Increased risk of rebleeding of peptic ulcer bleeding in patients with comorbid illness receiving omeprazole infusion. Hepatogastroenterology 50:2270-2273, 2003
11. Yang CC, Shin JS, Lin XZ, Hsu PI, Chen KW, Lin CY: The natural history (fading time) of stigmata of recent hemorrhage in peptic ulcer disease. Gastrointest Endosc 40:562-566, 1994
12. American Society of Anesthesiologists: New classification of physical status. Anesthesiology 24:111, 1963
13. Siringo S, Santoro P, Merighi S, Difebo G, McCormick PA, McIntyre N, Barbara L, Burroughs AK: Peptic ulceration and its complications in cirrhosis: an endoscopic and clinical survey in 2047 patients. Gut 31:A628, 1990 (abstract)
14. Langman MJ, Cooke AR: Gastric and duodenal ulcer and their associated diseases. Lancet 1:680-683, 1976
15. Cappell MS, Nadler SC: Increased mortality of acute upper gastrointestinal bleeding in patients with chronic obstructive pulmonary disease. A case controlled, multiyear study of 53 consecutive patients. Dig Dis Sci 40:256-262, 1995
16. Lightdale CJ, Kurtz RC, Sherlock P, Winawer SJ: Aggressive endoscopy in critically ill patients with upper gastrointestinal bleeding and cancer. Gastrointest Endosc 20:152-153, 1974
17. Tamawski A, Stachura J, Krause WJ, Douglass TG, Gergely H: Quality of gastric ulcer healing: a new, emerging concept. J. Clin. Gastroenterol. 13:S42-S47, 1991
18. Freston JW: Overview of medical therapy of peptic ulcer disease. Gastroenterol Clin North Am 9:121-140, 1990
19. Laterre PF, Horsmans Y: Intravenous omeprazole in critically ill patients: a randomized, crossover study comparing 40 with 80 mg plus 8 mg/hour on intragastric pH. Crit Care Med 29:1931-1935, 2001
20. Udd M, Miettinen P, Palmu A, Heikkinen M, Janatuinen E, Pasanen P, Tarvainen R, Kairaluoma MV, Lohman M, Mustonen H, Julkunen R: Regular-dose versus high-dose omeprazole in peptic ulcer bleeding: a prospective randomized double-blind study. Scand J Gastroenterol 36:1332-1338, 2001
21. Martin P: Wound healing - Aiming for perfect skin regeneration. Science 276:75-81, 1997
22. Bennett NT, Schultz GS: Growth factors and wound healing: biochemical properties of growth factors and their receptors. Am J Surg 165:728-737, 1993
23. Tamawski A: Cellular mechanisms of gastric ulcer healing. In The Stomach. W Domschke, SJ Konturek (eds). Berlin, Springer-Verlag, 1993, pp 177-192
24. Tarnawski A: Cellular and molecular mechanisms of ulcer healing. Drugs Today 33:697-706, 1997
25. Sung JJ, Chan FK, Lau JY, Yung MY, Leung WK, Wu JC, Ng EK, Chung SC: The effect of endoscopic therapy in patients receiving omeprazole for bleeding ulcers with nonbleeding visible vessels or adherent clots: a randomized comparison. Ann Intern Med 139:237-243, 2003
26. Lee KK, You JH, Wong IC, Kwong SK, Lau JY, Chan TY, Lau JT, Leung WY, Sung JJ, Chung SS : Cost-effectiveness analysis of high-dose omeprazole infusion as adjuvant therapy to endoscopic treatment of bleeding peptic ulcer. Gastrointest Endosc 57:160-164, 2003